Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate as a fixed-dose combination in Japanese and Caucasian healthy subjects

H. Tillmann (Basel, Switzerland), S. Inoue (Tokyo, Japan), S. Vaidya (Cambridge, United States of America), Y. Sakita (Tokyo, Japan), S. Machineni (Hyderabad, India), K. Kobayashi (Tokyo, Japan), K. Furihata (Tokyo, Japan)

Source: International Congress 2019 – Clinical studies of asthma treatments
Session: Clinical studies of asthma treatments
Session type: Thematic Poster
Number: 2541
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Tillmann (Basel, Switzerland), S. Inoue (Tokyo, Japan), S. Vaidya (Cambridge, United States of America), Y. Sakita (Tokyo, Japan), S. Machineni (Hyderabad, India), K. Kobayashi (Tokyo, Japan), K. Furihata (Tokyo, Japan). Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate as a fixed-dose combination in Japanese and Caucasian healthy subjects. 2541

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: